Protein variant presents a potential new target for developing effective treatments for Parkinson’s disease

Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson’s disease, which in the future may serve as a target for developing new treatments for this terrible ailment, affecting close to 10 million people worldwide.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup